Columbia University will receive $6.3 million from the National Institute of Allergy and Infectious Diseases and Harvard Medical School will receive $6 million to establish translational research centers where molecular diagnostics technologies will be developed. Harvard researchers will focus on discovering biomarkers of resistance, developing new clinical sampling techniques and developing a molecular diagnostic test for Mycobacterium tuberculosis. Columbia's Center for Research in Diagnostics and Discovery will involve researchers at multiple institutions collaborating to develop, validate and implement tools and strategies for detecting novel pathogens.

Related Summaries